Free public records show Jiangsu Hansoh Pharmaceutical Co., Ltd. in 12 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Jiangsu Hansoh Pharmaceutical Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
56 active studies led by Jiangsu Hansoh Pharmaceutical Co., Ltd., of 138 in all
Source: ClinicalTrials.gov, Studies with Jiangsu Hansoh Pharmaceutical Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
9 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Studies Jiangsu Hansoh Pharmaceutical Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Jiangsu Hansoh Pharmaceutical Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Jiangsu Hansoh Pharmaceutical Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Jiangsu Hansoh Pharmaceutical Co., Ltd. is in.
Stories on the topics Jiangsu Hansoh Pharmaceutical Co., Ltd. works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
ReadSearch all reports for Jiangsu Hansoh Pharmaceutical Co., Ltd. All companies